Table 1. Baseline characteristics of the... | American Society of Hematology

Table 1.

Baseline characteristics of the treated patients

DL	Patient no.	Disease type	Age	Sex	Race	Prior no. of therapies	Prior HSCT	Percentage of CD5 expression (%)
DL1, 1 × 10⁷/m²	2	MF/SS	63	F	White	18	Allogeneic	51
	3	AITL	70	M	White	2	Autologous	100
DL2, 5 × 10⁷/m²	5	AITL	63	F	White	7	Autologous	75
	6	PTCL	67	M	White	4	No	51
	14	PTCL	71	M	White	4	Autologous	100
	23	PTCL	48	M	White	10	No	55
DL3, 1 × 10⁸/m²	28	CTCL	29	F	White	7	No	80
	31	PTCL	63	M	Asian	5	Allogeneic	98
	32	ATLL	49	F	Black	5	No	56

DL	Patient no.	Disease type	Age	Sex	Race	Prior no. of therapies	Prior HSCT	Percentage of CD5 expression (%)
DL1, 1 × 10⁷/m²	2	MF/SS	63	F	White	18	Allogeneic	51
	3	AITL	70	M	White	2	Autologous	100
DL2, 5 × 10⁷/m²	5	AITL	63	F	White	7	Autologous	75
	6	PTCL	67	M	White	4	No	51
	14	PTCL	71	M	White	4	Autologous	100
	23	PTCL	48	M	White	10	No	55
DL3, 1 × 10⁸/m²	28	CTCL	29	F	White	7	No	80
	31	PTCL	63	M	Asian	5	Allogeneic	98
	32	ATLL	49	F	Black	5	No	56

ATLL, adult T-cell leukemia/lymphoma; CTCL, cutaneous T-cell lymphoma; F, female; M, male; MF/SS, mycosis fungoides/Sezary syndrome.